MOIG treatment inhibited the production of IL-1β, IL-6, IL-8 and TNF-α, and reduced the matrix degradation enzymes expressions of MMP2 and MMP3 in TNF-α-stimulated FLSs, thereby blocking the spread of arthritis to distant joints. The gene discussed is MMP2; the disease is arthritic joint disease.